Biomarin Pharmaceutical Inc

NORDEA INVESTMENT MANAGEMENT AB BMRN

Report date

9/30/2025

Quarter

2025 Q3

Filed

10/27/2025

Shares

18,679

Value ($000)

995

Weight

0.0%

2013 Q4 - 2025 Q3 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q3	10/27/2025	995	0.0%	18,679	9/30/2025
2025 Q2	7/29/2025	819	0.0%	14,944	6/30/2025
2025 Q1	5/14/2025	1,046	0.0%	14,878	3/31/2025
2024 Q4	1/6/2025	977	0.0%	14,822	12/31/2024
2024 Q3	11/5/2024	1,045	0.0%	14,822	9/30/2024
2024 Q2	8/8/2024	1,240	0.0%	14,852	6/30/2024
2024 Q1	5/2/2024	1,207	0.0%	13,675	3/31/2024
2023 Q4	1/10/2024	1,121	0.0%	11,594	12/31/2023
2023 Q3	11/13/2023	983	0.0%	11,050	9/30/2023
2023 Q2	7/7/2023	1,052	0.0%	11,571	6/30/2023
2023 Q1	4/19/2023	1,116	0.0%	11,571	3/31/2023
2022 Q4	2/8/2023	1,175	0.0%	11,571	12/31/2022
2022 Q3	10/19/2022	996	0.0%	11,571	9/30/2022
2022 Q2	8/9/2022	906	0.0%	10,990	6/30/2022
2022 Q1	4/11/2022	668	0.0%	8,628	3/31/2022
2021 Q4	1/20/2022	772	0.0%	8,628	12/31/2021
2021 Q3	11/1/2021	666	0.0%	8,628	9/30/2021
2021 Q2	7/16/2021	720	0.0%	8,628	6/30/2021
2021 Q1	5/17/2021	656	0.0%	8,628	3/31/2021
2020 Q4	2/12/2021	757	0.0%	8,628	12/31/2020
2020 Q3	11/9/2020	590	0.0%	7,680	9/30/2020
2020 Q2	8/13/2020	1,888	0.0%	15,360	6/30/2020
2020 Q1	5/15/2020	634	0.0%	7,680	3/31/2020
2019 Q4	2/11/2020	615	0.0%	7,297	12/31/2019
2014 Q2	7/22/2014	228	0.0%	3,663	6/30/2014
2014 Q1	4/22/2014	1,614	0.0%	23,663	3/31/2014
2013 Q4	1/23/2014	1,850	0.0%	26,297	12/31/2013